NFKB1 and glioblastoma: IL-1β silencing, however, did not increase the phosphorylated IκBα levels in RSL3-treated glioblastoma cells, implying that IL-1β expression is regulated by the NF-κB pathway, the activation of which is independent of IL-1β (Figure 2(c)).